Ben Tre Pharmaceutical JSC (HOSE:DBT)
Vietnam · Delayed Price · Currency is VND 13,100
0.00 (0.00%)
At close: Aug 13, 2026
HOSE:DBT Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Net Income | 26,224 | 14,203 | 14,581 | 16,195 | 21,396 | 20,193 |
Depreciation & Amortization | 17,754 | 17,649 | 17,109 | 8,884 | 13,336 | 13,007 |
Other Amortization | 396.64 | 761.61 | - | - | - | - |
Loss (Gain) From Sale of Assets | -14,946 | - | - | - | - | - |
Loss (Gain) From Sale of Investments | -19,927 | -19,927 | -6,478 | 4,054 | - | - |
Other Operating Activities | 5,560 | 3,561 | -4,195 | -1,440 | -7,223 | -4,208 |
Change in Accounts Receivable | 63,481 | -75,752 | 37,638 | -12,200 | 11,450 | -44,032 |
Change in Inventory | 18,320 | 45,125 | -108,917 | 65,536 | -104,463 | 18,380 |
Change in Accounts Payable | 27,553 | -493.26 | 16,154 | -84,186 | -9,390 | 914.59 |
Change in Other Net Operating Assets | 5,792 | 4,022 | 7,313 | 3,518 | 776.47 | -15,069 |
Operating Cash Flow | 169,700 | -10,851 | -26,796 | 361.64 | -74,118 | -10,814 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -4,001 | -2,779 | -14,072 | -7,318 | -6,822 | -10,513 |
Sale of Property, Plant & Equipment | 16,798 | 16,784 | 15,338 | 2,126 | - | 7,534 |
Investment in Securities | -8,999 | -8,999 | -19,496 | -32,965 | -28,148 | 2,557 |
Other Investing Activities | 7,395 | 5,270 | 3,036 | 2,812 | 6,570 | 8,519 |
Investing Cash Flow | -36,744 | 20,245 | -32,541 | -62,566 | -42,400 | 8,097 |
Long-Term Debt Issued | - | 880,491 | 888,931 | 782,262 | 697,476 | 538,385 |
Total Debt Issued | 853,267 | 880,491 | 888,931 | 782,262 | 697,476 | 538,385 |
Long-Term Debt Repaid | - | -876,901 | -861,447 | -719,327 | -592,327 | -537,279 |
Total Debt Repaid | -977,764 | -876,901 | -861,447 | -719,327 | -592,327 | -537,279 |
Net Debt Issued (Repaid) | -124,497 | 3,590 | 27,484 | 62,935 | 105,148 | 1,106 |
Issuance of Common Stock | - | - | 19,062 | 7,000 | 12,143 | - |
Repurchase of Common Stock | -20,000 | - | - | - | -97.85 | - |
Common Dividends Paid | - | - | - | - | -13,529 | -18,343 |
Financing Cash Flow | -144,497 | 3,590 | 46,546 | 69,935 | 103,665 | -17,237 |
Foreign Exchange Rate Adjustments | 2.97 | 4.39 | 6.49 | 23.19 | - | - |
Net Cash Flow | -11,538 | 12,988 | -12,785 | 7,754 | -12,853 | -19,954 |
Free Cash Flow | 165,699 | -13,630 | -40,869 | -6,956 | -80,940 | -21,328 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | 18.97% | -1.58% | -4.71% | -0.86% | -10.11% | -2.63% |
Free Cash Flow Per Share | - | -651.41 | -2187.12 | -409.38 | - | - |
Levered Free Cash Flow | 149,214 | -90.11 | -26,490 | - | -87,108 | 3,759 |
Unlevered Free Cash Flow | 161,881 | 25,317 | -1,419 | - | -77,618 | 12,015 |
Cash Interest Paid | 21,482 | 40,642 | 40,463 | 39,419 | 15,165 | 14,031 |
Cash Income Tax Paid | 621.44 | 10,262 | 10,687 | 1,915 | 3,736 | 3,117 |
Change in Working Capital | 154,640 | -27,098 | -47,813 | -27,332 | -101,627 | -39,806 |